MEDICAL DEVICE MANUFACTURERS ASSOCIATION lobbying for MEDICAL DEVICE MANUFACTURERS ASSOCIATION

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 15, 2026

Expenses

$300,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 6

Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Patent & Trademark Office (PTO)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 3723
Medical Device Electronic Labeling Act
HR 5662
Medical Device Recall Improvement Act
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Lobbying activity 7

Copyright/Patent/Trademark

Issues relating to the STRONGER Patents Act and Section 101 reform

Health Issues

Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding

Medicare/Medicaid

Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare

Taxation/Internal Revenue Code

Issues related to R&D tax credit, bonus depreciation, and interest deductability

Trade (domestic/foreign)

Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)

Budget/Appropriations

Issues related to appropriations and user fee funding for the Food and Drug Administration

Small Business

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program